Market Place
Sourcing Support
Gsk`s New CEO Looking For $2B-$4B Deals `Hiding In Plain Sight`
04 Feb 2026 //
FIERCE BIOTECH
GSK Prioritizes `Downstream Effects` Of Obesity Over GLP-1s
04 Feb 2026 //
BIOSPACE
As CEO, Luke Miels Wants GSK To Be More `Product-Centric`
04 Feb 2026 //
FIERCE PHARMA
Wave Life Sciences Expedites WVE-006 Regulatory Process
02 Feb 2026 //
GLOBENEWSWIRE
GSK Plans Up To 350 Job Cuts For R&D Team
02 Feb 2026 //
FIERCE BIOTECH
CareMed Chosen As National Specialty Pharmacy For Exdensur
29 Jan 2026 //
GLOBENEWSWIRE
Gsk`s Trelegy Ellipta Approved In China For Uncontrolled Asthma
28 Jan 2026 //
INDPHARMAPOST
GSK’s Arexvy, receives European approval for expanded use
26 Jan 2026 //
PRESS RELEASE
Alteogen Secures Exclusive License For Subcutaneous Dostarlimab
21 Jan 2026 //
PR NEWSWIRE
GSK Awards $2M to Bridge Vaccine Gaps, Commits $3M for 2026
21 Jan 2026 //
BUSINESSWIRE
GSK Announces Recipients of Linked by Lupus: Nearing $1 Million
20 Jan 2026 //
BUSINESSWIRE
GSK Names $1M Lupus Grant Recipients
20 Jan 2026 //
BUSINESSWIRE
GSK to buy RAPT Therapeutics in $2.2 Billion Deal
19 Jan 2026 //
REUTERS
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
17 Jan 2026 //
FIERCE PHARMA
Experts Question Fda`s Leucovorin Approval Standard
12 Jan 2026 //
RAPS
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Anaptys Seeks Dismissal Of Tesaro`s Anticipatory Breach Claim
08 Jan 2026 //
GLOBENEWSWIRE
GSK Inks Model Deal In $50M Bet On Noetik`s Cancer AI Platform
08 Jan 2026 //
BUSINESSWIRE
Helix, GSK Collaboration For Precision Medicine Advancement
07 Jan 2026 //
PR NEWSWIRE
GSK & Ionis`s `Functional Cure` For Hep B Proves Worth In Ph. 3
07 Jan 2026 //
BUSINESSWIRE
GSK`s Exdensur Gains Approval In Japan
06 Jan 2026 //
PRESS RELEASE
GSK`s Nucala Picks Up COPD Nod In China
05 Jan 2026 //
PRESS RELEASE
LIXTE And Collaborators Expand Clear Cell Ovarian Cancer Trial
23 Dec 2025 //
GLOBENEWSWIRE
Samsung to buy US drug production facility from GSK for $280 M
22 Dec 2025 //
REUTERS
GSK Resubmits Tebipenem HBr NDA To FDA For Complicated UTIs
19 Dec 2025 //
GLOBENEWSWIRE
CAMP4 & GSK Partner To Advance RNA-Based Therapeutics
18 Dec 2025 //
GLOBENEWSWIRE
GSK`s Saphnelo EU Approved For Self-Administered Lupus Pen
16 Dec 2025 //
PHARMIWEB
Glaxosmithkline’s Biologics Exdensur Receives Approval in US
16 Dec 2025 //
FDA
GSK`s Long-Acting Asthma Med Wins CHMP Backing
12 Dec 2025 //
FIERCE PHARMA
FDA Signs Off On Expansion For Gsk`s Blujepa To Treat Gonorrhea
12 Dec 2025 //
FIERCE PHARMA
Sanofi, GSK Ink Preclinical Pacts In Hunt For New Antibodies
10 Dec 2025 //
FIERCE BIOTECH
Oxford Biotherapeutics Collaborates With GSK On Cancer Antibody
10 Dec 2025 //
PHARMIWEB
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
09 Dec 2025 //
BIOSPACE
GSK India Plans Big `Reinvention`, MD Bhushan Akshikar Reveals
05 Dec 2025 //
ECONOMICTIMES
Pfizer, GSK, Shionogi Sponsor London Run Of AMR Musical
04 Dec 2025 //
FIERCE PHARMA
Bavarian Nordic Initiates DKK 500M Share Buy-Back Program
02 Dec 2025 //
GLOBENEWSWIRE
Haleon May Rope In Ex-Md Of Castrol India To Head Local Biz
29 Nov 2025 //
ECONOMICTIMES
GSK, Anaptysbio sue each other over Jemperli revenue
22 Nov 2025 //
BIOPHARMADIVE
GSK Fleming Initiative Launch New Fight Against Antimicrobial
21 Nov 2025 //
INDPHARMAPOST
GSK Partners LTZ Therapeutics For Advanced Cancer Treatments
21 Nov 2025 //
INDPHARMAPOST
GSK Picks 1st Biotech Partners Under $7 B Flagship Pact
20 Nov 2025 //
FIERCE BIOTECH
Flagship Signs ProFound, Quotient Deals in GSK Pact
20 Nov 2025 //
PR NEWSWIRE
Scynexis Transfers Brexafemme NDA to Gsk
19 Nov 2025 //
GLOBENEWSWIRE
GSK Pens $50M Pact To Join Big Pharma Peers In Emerging Modality
19 Nov 2025 //
FIERCE BIOTECH
Life Sciences` Top Women of 2025
17 Nov 2025 //
FIERCE PHARMA
BDCDA Protests GSK`s Circular On Expired Drug Return Policy
12 Nov 2025 //
PHARMABIZ
GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
10 Nov 2025 //
BUSINESS WIRE
NPPA Revokes Decision Denying GSK`s Antifungal Formulation
08 Nov 2025 //
PHARMABIZ
Pediatrician Group Declines to Back Leucovorin for Autism
31 Oct 2025 //
FIERCE PHARMA
GSK Points To `Macro Factors` To Explain US Shingrix Demand Crash
29 Oct 2025 //
BIOSPACE
Emma Walmsley Upholds £40B Sales Target In Final GSK CEO Report
29 Oct 2025 //
FIERCE PHARMA
GSK Loses Hope For CD226 Cancer Therapies, Dropping Ph. 2 Assets
29 Oct 2025 //
FIERCE BIOTECH
Viiv Healthcare Initiates `Risk To Reasons` Program for Women
28 Oct 2025 //
PHARMIWEB
GSK Pens $750M Deal For COPD-Focused Oligonucleotide In Phase 1
28 Oct 2025 //
FIERCE BIOTECH
Biogen Seeks To Stand Out In Lupus With New Anti-CD40L Data
28 Oct 2025 //
BIOSPACE
GSK Acquires Prostate-Cancer Candidate From Syndivia For £268M
27 Oct 2025 //
FIERCE BIOTECH
New Global Coalition Launches to Hidden Threat of RSV in Adults
26 Oct 2025 //
GLOBENEWSWIRE
US FDA Approves Gsk`s Blood Cancer Treatment
25 Oct 2025 //
REUTERS
Glaxosmithkline’s Biologics Blenrep Receives Approval in US
23 Oct 2025 //
FDA
GSK Unveils Pivotal Data on Oral Antibiotic Ahead of FDA Filing
22 Oct 2025 //
PRESS RELEASE
